Dyskinesias encompass a variety of different hyperkinetic phenomenologies, particularly chorea, dystonia, stereotypies, and akathisia. The main types of drug-induced dyskinesias include levodopa-induced dyskinesia (LID) in patients with Parkinson's disease and tardive syndrome (TS), typic...
Dyskinesias encompass a variety of different hyperkinetic phenomenologies, particularly chorea, dystonia, stereotypies, and akathisia. Levodopa-induced dyskinesia (LID) is one of the main types of drug-induced dyskinesia, occurring in patients with Parkinson's disease (PD) who have been treated ...
网络药物所致肌张力障碍;药物诱发张力障碍 网络释义
Parkinsonism, tremor, chorea-ballismus, dystonia, tardive dyskinesia, myoclonus, tics and akathisia can be induced by many drugs. The drugs that are most frequently implicated in movement disorders are antipsychotics, calcium antagonists, orthopramides and substituted benzamides (e.g. metoclopramide,...
Dystonia induced by wearing-off or peak-dose effect can also be treated by anticholinergics [58]. The medications in this class group include benztropine mesylate injection with brand name Cogentin®, trihexyphenidyl Hydrochloride found in tablet and elixir form under the brand name Artane®, ...
Dystonia:Symptoms of dystonia may occur in susceptible individuals during the first days of treatment and at low doses. Pregnancy:Adequate and well-controlled studies to assess the risks of REXULTI during pregnancy have not been conducted. REXULTI should be used during pregnancy on...
Dystonia:Symptoms of dystonia may occur in susceptible individuals during the first days of treatment and at low doses. Pregnancy:Adequate and well-controlled studies to assess the risks of REXULTI during pregnancy have not been conducted. REXULTI should be used during pregnancy only if the benefit...
M. Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia. Mov. Disord. 17, 145–149 (2002). Article PubMed Google Scholar Porcella, A., Maxia, C., Gessa, G. L. & Pani, L. The synthetic cannabinoid ...
Nevertheless, patients requiring drug treatment for dystonia continue routinely to have to deal with both incomplete symptom control and a range of unpleasant adverse effects. The quest for more effective, more specific and better tolerated therapies, therefore, goes on. As the range of agents under...
Excessive dopaminergic activity can lead to hyperkinetic disorders such as tremors, tics, myoclonus, dystonia, and chorea, while reduced activity is associated with hypokinetic conditions, including Parkinson’s disease9,10,11. Given VMAT2’s critical role in dopamine regulation, inhibiting its ...